Back to top
more

Zimmer Biomet (ZBH)

(Delayed Data from NYSE)

$122.97 USD

122.97
701,655

-0.38 (-0.31%)

Updated Dec 2, 2022 04:04 PM ET

After-Market: $122.99 +0.02 (0.02%) 6:54 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.51%
2Buy17.96%
3Hold9.47%
4Sell5.16%
5Strong Sell2.21%
S&P50010.66%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 34% (164 out of 250)

Industry: Medical - Products

Trades from $1

Balance Sheet

Research for ZBH

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Zimmer Biomet Holdings, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Assets          
Cash & Equivalents 479 802 618 543 524
Receivables 1,405 1,453 1,364 1,276 1,495
Notes Receivable 0 0 0 0 0
Inventories 2,395 2,451 2,385 2,257 2,082
Other Current Assets 607 378 357 352 415
Total Current Assets 4,885 5,083 4,724 4,427 4,515
Net Property & Equipment 2,017 2,048 2,077 2,015 2,039
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 15,492 16,317 16,857 17,279 19,022
Deposits & Other Assets 1,063 969 980 405 389
Total Assets 23,456 24,418 24,639 24,127 25,965
Liabilities & Shareholders Equity 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Notes Payable 0 0 0 0 0
Accounts Payable 351 330 401 363 330
Current Portion Long-Term Debt 1,605 500 1,500 525 1,225
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 65 60 127 142 165
Other Current Liabilities 1,447 1,667 1,414 1,391 1,300
Total Current Liabilities 3,468 2,557 3,442 2,421 3,020
Mortgages 0 0 0 0 0
Deferred Taxes/Income 666 790 840 1,000 1,102
Convertible Debt 0 0 0 0 0
Long-Term Debt 5,464 7,627 6,721 8,414 8,918
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1,193 1,245 1,243 1,016 1,190
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 10,790 12,218 12,246 12,851 14,229
Shareholders Equity 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Preferred Stock 0 0 0 0 0
Common Stock (Par) 3 3 3 3 3
Capital Surplus 9,315 9,122 8,920 8,686 8,515
Retained Earnings 10,292 10,087 10,427 9,491 10,023
Other Equity -226 -293 -237 -183 -84
Treasury Stock 6,718 6,720 6,721 6,722 6,722
Total Shareholder's Equity 12,666 12,199 12,393 11,276 11,736
Total Liabilities & Shareholder's Equity 23,456 24,418 24,639 24,127 25,965
Total Common Equity 12,666 12,199 12,393 11,276 11,736
Shares Outstanding 208.90 207.20 205.60 203.90 202.40
Book Value Per Share 60.63 58.88 60.28 55.30 57.98

Fiscal Year End for Zimmer Biomet Holdings, Inc falls in the month of December.

All items in Millions except Per Share data.

9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021
Assets          
Cash & Equivalents 545 386 436 479 920
Receivables 1,279 1,282 1,254 1,405 1,392
Notes Receivable 0 0 0 0 0
Inventories 2,129 2,123 2,132 2,395 2,517
Other Current Assets 582 672 695 607 483
Total Current Assets 4,534 4,463 4,517 4,885 5,312
Net Property & Equipment 1,802 1,797 1,826 2,017 2,008
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 13,935 14,173 14,287 15,492 15,682
Deposits & Other Assets 1,062 1,020 987 1,063 1,006
Total Assets 21,333 21,453 21,618 23,456 24,009
Liabilities & Shareholders Equity 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021
Notes Payable 0 0 0 0 0
Accounts Payable 334 307 322 351 328
Current Portion Long-Term Debt 659 852 1,015 1,605 1,046
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 233 185 0 0
Income Taxes Payable 30 38 35 65 121
Other Current Liabilities 1,272 1,034 1,119 1,447 1,445
Total Current Liabilities 2,296 2,464 2,674 3,468 2,939
Mortgages 0 0 0 0 0
Deferred Taxes/Income 541 526 490 666 694
Convertible Debt 0 0 0 0 0
Long-Term Debt 5,055 5,172 5,286 5,464 6,458
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1,190 1,146 1,193 1,203
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 9,082 9,328 9,596 10,790 11,294
Shareholders Equity 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021
Preferred Stock 0 0 0 0 0
Common Stock (Par) 3 3 3 3 3
Capital Surplus 9,464 9,419 9,386 9,315 9,295
Retained Earnings 9,740 9,607 9,503 10,292 10,426
Other Equity -239 -186 -153 -226 -293
Treasury Stock 6,717 6,718 6,718 6,718 6,718
Total Shareholder's Equity 12,251 12,125 12,021 12,666 12,714
Total Liabilities & Shareholder's Equity 21,333 21,453 21,618 23,456 24,009
Total Common Equity 12,251 12,125 12,021 12,666 12,714
Shares Outstanding 209.80 209.80 209.50 208.90 208.90
Book Value Per Share 58.39 57.79 57.38 60.63 60.86